IDIA — Idorsia Share News
0.000.00%
Last trade - 00:00- CH₣1.13bn
- CH₣2.28bn
- CH₣220.58m
Brief: A Factory In A Lab Idorsia's Breakthrough Synthetic Glycan Vaccine Platform Validated For The First Time In Humans
Brief: Idorsia Says Bondholders Approve Amended Terms Of The 2025 And 2028 Convertible Bonds
Offer To Exchange Senior Unsecured Convertible Bonds Due 2025 And 2028
Idorsia names director Srishti Gupta as new CEO
Swiss stocks - Factors to watch on May 28
Brief: Idorsia Q1 EBIT CHF 67 Mln
Brief: Idorsia Announces Positive Data With Daridorexant In Patients With Chronic Insomnia And Nocturia
Brief: Idorsia Full Year EPS -1.45 Chf
Swiss stocks - Factors to watch on February 26
Brief: Idorsia Reaches Agreement With Significant Bondholders To Restructure Convertible Bond Debt
Brief: Idorsia And Viatris Update Collaboration For Selatogrel And Cenerimod
Brief: Idorsia Released From Exclusivity Constraint Regarding Global Rights To Aprocitentan
Brief: Idorsia Says Bondholders Approve Amended Terms Of The 2025 Convertible Bonds
Swiss stocks - Factors to watch on February 13
Brief: Idorsia Publishes The Resolutions For The Upcoming Bondholder Meeting
Brief: UK'S MHRA Says Aprocitentan Approved To Treat Adults With Hypertension
Factbox: European companies cut jobs as economy sputters
Brief: Idorsia Intends To Publish Invitation To Bondholder Meeting
Factbox: European companies cut jobs as economy sputters